170706 ⎘
Assays, e.g. immunoassays or enzyme assays, involving carbohydrates; Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters; Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
BIOMARKERS FOR MULTIPLE SCLEROSIS
#2LEAKY JOINT SYNDROME DIAGNOSTICS AND TREATMENTS
#3BIOMARKERS OF FIBROSIS AND USES THEREFOR
#4ELEVATION OF GLYCOSAMINOGLYCANS IN SUBJECTS WITHOUT MUCOPOLYSACCHARIDOSIS
#5BIOMARKERS FOR IDIOPATHIC PULMONARY FIBROSIS AND METHODS OF PRODUCING AND USING SAME
#6Atomic Description of Immune Complex that Causes Heparin-Induced Thrombocytopenia
#7GLYCOSAMINOGLYCAN ARTICLES AND METHODS RELATING THERETO
#8GLX-DERIVED MOLECULE DETECTION
#9Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression
#10METHODS OF DIAGNOSING AND TREATING OSTEOARTHRITIS
#11METHODS FOR TREATING A SUBTYPE OF COLORECTAL CANCER
#12BIOMARKERS FOR MULTIPLE SCLEROSIS
#13Atomic description of immune complex that causes heparin-induced thrombocytopenia
#14CANCER BIOMARKERS
#15ANALYTICAL METHOD FOR GLYCOSAMINOGLYCANS
#16SYSTEM AND METHOD OF NOISE REDUCTION IN BLOOD PANELS
#17BIOMARKERS OF RENAL INJURY
#18FFN FLUORESCENCE RELEASE ASSAY (FFRA) AND METHODS OF USING SAME
#19NANOPARTICLE PROBES AND METHODS OF MAKING AND USE THEREOF
#20BIOMARKER COMBINATIONS TO SIMULTANEOUSLY EVALUATE NON-ALCOHOLIC STEATOHEPATITIS AND HEPATIC FIBROSIS STATUS
#21METHOD FOR DETECTING CONTENT OF GLYCOSAMINOGLYCAN CARBOXYLATED DERIVATIVE IN SAMPLE, AND APPLICATION THEREOF
#22METHODS FOR TREATING INHERITED METABOLIC DISORDERS
#23POLYPEPTIDES BINDING SELECTIVELY HEPARIN OR HEPARAN SULFATE GLYCOSAMINOGLYCANS AND CELL-PENETRATING POLYPEPTIDES COMPRISING THE SAME
#24Detecting microbial infection in wounds
#25BLOOD CHARACTERISTICS EVALUATION APPARATUS, BLOOD CHARACTERISTICS EVALUATION METHOD, AND NON-TRANSITORY COMPUTER READABLE RECORDING MEDIUM
#26DETECTING MICROBIAL INFECTION IN WOUNDS
#27METHOD FOR IMMUNOASSAY OF AMYLOID BETA IN BLOOD, AND KIT FOR SAME
#28Atomic description of immune complex that causes heparin-induced thrombocytopenia
#29Methods of treating gastrointestinal diseases characterized by inflammatory cells
#30Method for analyzing glycosaminoglycan
#31TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURONATE-2-SULFATASE (IDS) PRODUCED BY HUMAN NEURAL OR GLIAL CELLS
#32ANTIBODIES TO DISULFATED HEPARIN DISACCHARIDE IN THE DIAGNOSIS OF NEUROPATHY
#33ANTIBODY-BASED METHOD TO IDENTIFY, PURIFY, AND MANIPULATE CELL TYPES AND PROCESSES
#34Detection of Glycosaminoglycans
#35Methods for categorizing and treating subjects having cystic fibrosis (CF) and at risk for severe pulmonary exacerbation
#36Detection of exosomes having surface markers
#37NANOPARTICLE PROBES AND METHODS OF MAKING AND USE THEREOF
#38Biomarkers of vascular disease
#39GLX-DERIVED MOLECULE DETECTION
#40ESOPHAGEAL CANCER MARKER AND USE THEREOF
#41ISOLATION OF CIRCULATING CELLS OF FETAL ORIGIN USING RECOMBINANT MALARIA PROTEIN VAR2CSA
#42Biomarkers for multiple sclerosis
#43Use of ZC3H12B gene or protein and method for establishing animal model of liver disease
#44Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#45METHODS AND SYSTEMS FOR PREDICTING DRUG-RESPONSE
#46BIOMARKERS FOR RADIATION TREATMENT
#47DENDRITIC CELL IMMUNORECEPTOR AGONIST
#48DETECTION OF OLIGOSACCHARIDES
#49ANTIBODIES TO DISULFATED HEPARIN DISACCHARIDE IN THE DIAGNOSIS OF NEUROPATHY
#50Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression
#51Biomarker combinations to simultaneously evaluate non-alcoholic steatohepatitis and hepatic fibrosis status
#52Saccharide-based biomarkers and therapeutics
#53Methods for detecting sinusoidal obstructive syndrome (SOS)
#54Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#55Biomarkers of renal injury
#56Nanoparticle probes and methods of making and use thereof
#57Atomic description of immune complex that causes heparin-induced thrombocytopenia
#58Home evaluation of the quality of semen samples
#59METHODS AND COMPOSITIONS FOR THE EVALUATION OF RENAL INJURY USING HYALURONIC ACID
#60Marker and Method for Determining the Composition or Purity of a Cell Culture and for Determining In Vitro the Identity of a Cartilage Cell or Synovial Cell
#61Method for the quantification of parasite eggs in feces
#62Methods for categorizing and treating subjects at risk for pulmonary exacerbation and disease progression
#63CELL SURFACE PROSTATE CANCER ANTIGEN FOR DIAGNOSIS
#64EVALUATION OF THE SEVERITY OF PATIENTS WITH FLAVIVIRUS INFECTION BY BLOOD HYALURONAN LEVELS AND THERAPEUTIC AGENTS TO BLOCK THE HYALURONAN
#65Detection of exosomes having surface markers
#66DIAGNOSTIC METHOD FOR URINARY TRACT INFECTION
#67ANTIBODIES AGAINST GLYPICAN-3 AND THEIR USES IN CANCER DIAGNOSIS AND TREATMENT
#68Biomarkers of vascular disease
#69ESOPHAGEAL CANCER MARKER AND USE THEREOF
#70Activation assay for the diagnosis of a heparin-induced thrombocytopenia
#71Method for measuring clotting time, measurement device for clotting time, and reagent kit
#72Method for separating the fraction bound to glycosaminoglycans and applications thereof
#73Biomarkers for radiation treatment
#74ANTIBODIES TO DISULFATED HEPARIN DISACCHARIDE IN THE DIAGNOSIS OF NEUROPATHY
#75Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#76Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
#77DIAGNOSTIC TEST FOR ALZHEIMER'S DISEASE BASED ON IDENTIFICATION OF A PROTEOLYTIC PATHWAY
#78BIOLOGICAL ASSAY OF PEPTIDOGLYCANS
#79Home evaluation of the quality of semen samples
#80Detection method for low molecular weight heparin complete degradation products using hydrophilic interaction chromatography and multiple reaction monitoring tandem mass spectrometry
#81Human monoclonal antibodies specific for glypican-3 and use thereof
#82Detection of oligosaccharides
#83Method for the quantification of parasite eggs in feces
#84METHOD FOR MEASURING CLOTTING TIME, MEASUREMENT DEVICE FOR CLOTTING TIME, AND REAGENT KIT
#85Atomic description of immune complex that causes heparin-induced thrombocytopenia
#86Nanoparticle probes and methods of making and use thereof
#87Determination of glycosaminoglycan levels by mass spectrometry
#88Non-invasive method for assessing liver fibrosis progression
#89Nanoparticle probes and methods of making and use thereof
#90Saccharide-based biomarkers and therapeutics
#91SYSTEMS AND METHODS OF DETECTING SOLID TUMOR CANCER
#92Hyaluronic acid-based nanoparticles as biosensors for imaging-guided surgery and drug delivery vehicles and methods associated therewith
#93Methods and systems for predicting drug-response
#94Antibody fragments for detecting cancer and methods of use
#95ANTIBODIES TO DISULFATED HEPARIN DISACCHARIDE IN THE DIAGNOSIS OF NEUROPATHY
#96Anti-chondroitin-sulfate-E antibody
#97METHODS AND COMPOSITIONS FOR THE EVALUATION OF RENAL INJURY USING HYALURONIC ACID
#98Esophageal cancer marker and use thereof
#99S100P AND HYALURONIC ACID AS BIOMARKERS FOR METASTATIC BREAST CANCER
#100Cell surface prostate cancer antigen for diagnosis
#101Method for separating hyaluronan and quantifying its molecular mass distribution in biological samples
#102BIOMARKERS FOR DETECTION AND DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA
#103DRUG DELIVERY SYSTEM
#104Method for diagnosing lung diseases
#105METHODS OF MANUFACTURING POLYSACCHARIDE COMPOSITIONS
#106Diagnostic method for urinary tract infection
#107Methods of isolating extracellular vesicles
#108Human monoclonal antibodies specific for glypican-3 and use thereof
#109NANOSENSOR FOR DETECTING THE ACTIVITY OF GLYCOSAMINOGLYCAN-CLEAVING ENZYMES AND USES THEREOF
#110Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#111Method for enrichment and separation of spinal fluid glycoprotein, method for searching for marker for central nervous system diseases which utilizes the aforementioned method, and marker for central nervous system diseases
#112Preventive and therapeutic drug for cartilaginous hyperplasia and method of screening for the same
#113Method for investigation of liver damage type
#114Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
#115Non invasive method for prenatal diagnosis
#116Biological assay of peptidoglycans
#117Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
#118Biomarkers for radiation treatment
#119Human monoclonal antibodies specific for glypican-3 and use thereof
#120Urinary biomarkers for predicting long-term dialysis
#121Method for treating pulmonary exacerbation and disease progression in subjects having cystic fibrosis
#122Mucopolysaccharidosis IVA/VII screening and treatment method
#123Detection of oligosaccharides
#124CIRCULATING BIOMARKERS FOR DISEASE
#125ASSAYS FOR DETECTION OF GLYCOSAMINOGLYCANS
#126METHODS FOR USING LIPID PARTICLES
#127Methods for detecting heparin/platelet factor 4 antibodies
#128EVALUATING RENAL INJURY USING HYALURONIC ACID
#129Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
#130Carbohydrate detection
#131Quantifying local inflammatory activity and its use to predict disease progression and tailor treatments
#132Method of Simultaneous Detection of Heparin-Induced Immunoglobulins Types G, A and M
#133TARGET AFFINITY MATERIAL INCLUDING BIODEGRADABLE POLYMER AND USE THEREOF
#134METHODS AND KITS FOR DIAGNOSING HEPARIN-INDUCED THROMBOCYTOPENIA
#135Methods of detecting glycosaminoglycans
#136METHODS AND ASSAYS FOR OVERSULFATED GLYCOSAMINOGLYCANS
#137Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
#138Method of detecting the presence of an antibody in a sample
#139Urinary biomarkers for predicting long-term dialysis
#140Method for functionalizing a porous membrane covering of an optical sensor to facilitate coupling of an antithrom-bogenic agent
#141Biomarkers for myocardial ischemia
#142Capillary electrophoresis method for fine structural analysis of enoxaparin sodium
#143Glycan arrays and methods for their fabrication
#144Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
#145Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#146Assays for detection of glycosaminoglycans
#147Hyaluronic acid decomposition-promoting factor and inhibitor thereof
#148ANALYSIS OF SULFATED POLYSACCHARIDES
#149DENDRITIC CELL IMMUNORECEPTOR AGONIST
#150Methods for analyzing a heparin sample
#151METHODS OF EVALUATING CELLS AND CELL CULTURES
#152SLE-DC-MEDIATED ENHANCED IgG- AND IgA-SECRETING B CELL RESPONSES
#153Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#154Antibodies to disulfated heparin disaccharide in the diagnosis of neuropathy
#155METHODS OF EVALUATING CELLS AND CELL CULTURES
#156BIOMARKERS FOR DETECTION AND DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA
#157SULFATED POLYSACCHARIDES HAVING ANTIPLASMODIAL ACTIVITY AND METHODS AND PRODUCTS FOR IDENTIFYING ANTIPLASMODIAL ACTIVITY
#158Method for determining biologically active HGF
#159Biomarkers of renal injury
#160Methods to Distinguish Different Disaccharide Products after Digestion with Heparinases
#161Quantifying local inflammatory activity and its use to predict disease progression and tailor treatments
#162Non-Invasive Method for Assessing Liver Fibrosis Progression
#163Method of measuring the concentration of a glycosaminoglycan anticoagulant
#164Detection of oligosaccharides
#165Reagents and Methods for Assessment of Human Tumor Malignancy and for Targeting Malignant Tumor Cells
#166Biomarkers for myocardial ischemia
#167Method for assaying keratan sulfate, assay kit therefor and method for detecting joint disease by using the same
#168Polymer end group detection
#169ANALYSIS OF SULFATED POLYSACCHRIDES
#170Blood group antigens of different types for diagnostic and therapeutic applications
#171Method for detecting lysosomal storage diseases
#172Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
#173NOVEL PROTEIN CAPABLE OF BINDING TO HYALURONIC ACID, AND METHOD FOR MEASUREMENT OF HYALURONIC ACID USING THE SAME
#174COMPOSITION AND METHOD FOR DIAGNOSING FUNGAL DISEASE
#175METHODS FOR DETECTING AND QUANTIFYING OVERSULFATED GLYCOSAMINOGLYCANS
#176Activated partial thromboplastin time measuring reagent, activated partial thromboplastin time measuring method, and determination method for determining presence or absence of blood coagulation inhibitor
#177Methods for determining oligosaccharide binding
#178Protein capable of binding to hyaluronic acid, and method for measurement of hyaluronic acid using the same
#179Method for finger-printing heparins
#180Compositions of and methods of using sulfatases from
#181IDENTIFYING HAEMATOPOIETIC STEM CELLS BASED ON CELL SURFACE MARKERS
#182SELECTING/IDENTIFYING AND ADMINISTERING ACTIVE AGENTS USEFUL FOR MODIFYING THE SHAPE OF KERATIN/HAIR FIBERS
#183Rapid and sensitive method for quantitative determination of the level of heparin—PF4 complex induced immunoglobulin antibodies
#184GLYCOSAMINOGLYCAN-COATED PARTICLES AND USES THEREOF
#185Detection of oligosaccharides
#186METHOD FOR MEASURING HYALURONIC ACID USING HYALURONIC ACID BINDING PROTEIN
#187Method for determining endoglycosidase (heparanase) enzyme activity
#188Heparin Compositions and Selectin Inhibition
#189Urinary biomarkers to predict long-term dialysis
#190Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#191Methods for analyzing or processing a heparin sample
#192Method for determination of molecular weight of hyaluronic acid
#193SYSTEM TO ASSESS THE BIOLOGICAL ACTIVITY OF CHEMOATTRACTANTS
#194Method and kit for the detection of heparin-dependent antibodies and the diagnosis of immune or autoimmune pathologies potentiated by heparin, such as heparin-induced thrombocytopenia
#195HEPARAN SULFATE PROTEOGLYCAN COMPOSITION AND USE THEREOF
#196Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma
#197Intracellular targeting of molecules via syndecan-4
#198Methods and assays for oversulfated glycosaminoglycans
#199Method for detecting lysosomal storage diseases
#200Compositions of and methods of using sulfatases from flavobacterium heparinum
#201Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#202Anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate
#203NOVEL BIOMARKERS FOR DIAGNOSIS AND/OR PROGNOSIS OF NEOPLASIAS IN ANIMALS
#204METHODS OF OLIGOSACCHARIDE PROFILING FOR THE DETECTION OF OCULAR ROSACEA
#205Heparanase specific molecular probes and their use in research and medical applications
#206Analysis of sulfated polysaccharides
#207Method for measuring the concentration of a glycosaminoglycan anticoagulant
#208Methods of evaluating cells and cell cultures
#209Identifying haematopoietic stem cells based on cell surface markers
#210Rapid induction of Alzheimer's amyloid plaque formation by sulfated glycosaminoglycans
#211Antibody specific for a chondroitin sulphate epitope
#212Diagnostic Methods Of Multiple Organ Amyloidosis
#213Chondroitin sulfate binding proteins and modulators thereof
#214Galectin-glycosaminoglycan complex and method for controlling galectin activity
#215Method for Measuring Hyaluronic Acid Using Hyaluronic Acid Binding Protein
#216Method and system for predicting liver fibrosis and related pathologies
#217Blood group antigens of different types for diagnostic and therapeutic applications
#218Screening of anti-viral drugs and pharmaceuticals composition containing thiazolidinone derivatives
#219Inhibitors of gob-4 protein as asthma therapeutics
#220Methods for evaluating the quality of a heparin sample
#221Methods and producing low molecular weight heparin
#222Factor Xa-based heparin assay using a heparin-modifying component
#223Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass
#224Heparin compositions and selectin inhibition
#2252-O sulfatase compositions and methods of hydrolyzing therewith
#2262-O sulfatase compositions and methods of degradation therewith
#2272-O sulfatase compositions and methods of analyzing therewith
#2282-O sulfatase nucleic acid compositions
#229Oligosaccharide biomarkers for mucopolysaccharidoses and other related disorders
#230Methods of screening for anti-inflammatory drugs and use thereof
#231Methods and kits for detecting heparin/platelet factor 4 antibodies
#232Particle-based multiplex assay for identifying glycosylation
#233Hyaluronan receptor for endocytosis
#234Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis
#235Methods and products related to evaluating the quality of a polysaccharide
#236Method for diagnosis of thrombotic disorders
#237Device and method for measuring glycosaminoglycans in body fluids
#238Method for detecting lysosomal storage diseases
#239Nucleic acids encoding rat hyaluronan receptor for endocytosis
#2402-O sulfatase compositions and related methods
#241Detection of haematopoietic stem cells and progeny and uses thereof